UB Paderborn / Katalog / Suche / in CDI

Classical Complement Pathway in Experimental Autoimmune Myasthenia Gravis Pathogenesis

Annals of the New York Academy of Sciences, 2008-06, Vol.1132 (1), p.210-219

2008

Link zum Volltext

Verfügbarkeit prüfen

A New Mouse Model of Autoimmune Ocular Myasthenia Gravis

Investigative ophthalmology & visual science, 2007-11, Vol.48 (11), p.5101-5111

2007

Link zum Volltext

Verfügbarkeit prüfen

Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice

Immunology letters, 2015-12, Vol.168 (2), p.306-312

2015

Link zum Volltext

Verfügbarkeit prüfen

CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis

Journal of neuroimmunology, 2012-08, Vol.249 (1), p.1-7

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting Cyclin D1 in Non-small Cell Lung Cancer and Mesothelioma Cells by Antisense Oligonucleotides

Anticancer research, 2011-11, Vol.31 (11), p.3683-3690

2011

Link zum Volltext

Verfügbarkeit prüfen

Ocular and generalized myasthenia gravis induced by human acetylcholine receptor γ subunit immunization

Muscle & nerve, 2012-02, Vol.45 (2), p.209-216

2012

Link zum Volltext

Verfügbarkeit prüfen

Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis

Cellular immunology, 2011, Vol.271 (2), p.292-298

2011

Link zum Volltext

Verfügbarkeit prüfen

Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2011-05, Vol.234 (1), p.165-167

2011

Link zum Volltext

Verfügbarkeit prüfen

Pros and cons of treating murine myasthenia gravis with anti-C1q antibody

Journal of neuroimmunology, 2007-01, Vol.182 (1), p.167-176

2007

Link zum Volltext

Verfügbarkeit prüfen

Targeting classical complement pathway to treat complement mediated autoimmune diseases

Advances in experimental medicine and biology, 2008-01, Vol.632, p.265

2008

Link zum Volltext

Verfügbarkeit prüfen

Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis

Journal of neuroimmunology, 2006-12, Vol.181 (1), p.29-33

2006

Link zum Volltext

Verfügbarkeit prüfen

Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis

Journal of neuroimmunology, 2009-03, Vol.208 (1), p.40-45

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory IgG receptor FcγRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2008-02, Vol.194 (1), p.44-53

2008

Link zum Volltext

Verfügbarkeit prüfen

C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2008-05, Vol.196 (1), p.101-106

2008

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis

Neuromuscular disorders : NMD, 2006-02, Vol.16 (2), p.137-143

2006

Link zum Volltext

Verfügbarkeit prüfen

The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit

Journal of neuroimmunology, 2005-12, Vol.169 (1), p.177-179

2005

Link zum Volltext

Verfügbarkeit prüfen

The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase

Inflammation, 2003-04, Vol.27 (2), p.79

2003

Link zum Volltext

Verfügbarkeit prüfen

Multiple Tyrosine Protein Kinases in Rat Hippocampal Neurons: Isolation of Ptk-3, a Receptor Expressed in Proliferative Zones of the Developing Brain

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (5), p.1819-1823

1994

Link zum Volltext

Verfügbarkeit prüfen

Ocular myasthenia gravis induced by human acetylcholine receptor subunit immunization in HLA DR3 transgenic mice

Immunology letters, 2015-12, Vol.168 (2), p.306-312

2015

Link zum Volltext

Verfügbarkeit prüfen

Frequency of acetylcholine receptor specific B cells correlates with experimental myasthenia gravis severity (137.5)

The Journal of immunology (1950), 2009-04, Vol.182 (1_Supplement), p.137-137.5

2009

Link zum Volltext

Verfügbarkeit prüfen

Melittin Binds to Secretory Phospholipase A2and Inhibits Its Enzymatic Activity

Biochemical and biophysical research communications, 1997-09, Vol.238 (2), p.436-442

1997

Link zum Volltext

Verfügbarkeit prüfen

CD4+ T cell independent LPS induced experimental autoimmune myasthenia gravis (EAMG)

The FASEB journal, 2008-03, Vol.22 (S1)

2008

Link zum Volltext

Verfügbarkeit prüfen

Genetic evidence for the involvement of Fcγ receptor III in experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2006-05, Vol.174 (1), p.157-167

2006

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2008-02, Vol.194 (1-2), p.44-53

2008

Link zum Volltext

Verfügbarkeit prüfen

Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis

Journal of neuroimmunology, 2006-05, Vol.174 (1-2), p.157

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Classical Complement Pathway in Experimental Autoimmune Myasthenia Gravis Pathogenesis

A New Mouse Model of Autoimmune Ocular Myasthenia Gravis

Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice

CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis

Targeting Cyclin D1 in Non-small Cell Lung Cancer and Mesothelioma Cells by Antisense Oligonucleotides

Ocular and generalized myasthenia gravis induced by human acetylcholine receptor γ subunit immunization

Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis

Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis

Pros and cons of treating murine myasthenia gravis with anti-C1q antibody

Targeting classical complement pathway to treat complement mediated autoimmune diseases

Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis

Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis

Inhibitory IgG receptor FcγRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis

Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis

The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit

The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase

Multiple Tyrosine Protein Kinases in Rat Hippocampal Neurons: Isolation of Ptk-3, a Receptor Expressed in Proliferative Zones of the Developing Brain

Ocular myasthenia gravis induced by human acetylcholine receptor subunit immunization in HLA DR3 transgenic mice

Frequency of acetylcholine receptor specific B cells correlates with experimental myasthenia gravis severity (137.5)

Melittin Binds to Secretory Phospholipase A2and Inhibits Its Enzymatic Activity

CD4+ T cell independent LPS induced experimental autoimmune myasthenia gravis (EAMG)

Genetic evidence for the involvement of Fcγ receptor III in experimental autoimmune myasthenia gravis pathogenesis

Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis

Suchergebnisse filtern